Incyte is a Delaware-based pharmaceutical company that develops and commercializes molecule drugs for the treatment of skin diseases.
Business Model:
Revenue: $3.4B
Employees: 1,001-5,000
Address: 1801 Augustine Cut-off
City: Wilmington
State: DE
Zip: 19803
Country: US
Incyte is a Delaware-based pharmaceutical company that develops and commercializes molecule drugs for the treatment of skin diseases.
Contact Phone:
+13024986700
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/12/1993
Ticker Symbol:
INCY
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2001 | De Novo Pharmaceuticals | Series B | 0 |
6/2000 | GeneEd | Seed Round | 0 |
3/2002 | Iconix Biosciences | Venture Round | 0 |
2/2017 | Agenus | Post-IPO Equity | 0 |
2/2017 | Agenus | Post-IPO Equity | 0 |
3/2002 | Iconix Biosciences | Venture Round | 0 |
7/2001 | De Novo Pharmaceuticals | Series B | 0 |
6/2000 | GeneEd | Seed Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
5/2016 | ARIAD Pharmaceuticals - European operations | |
2/2003 | Maxia Pharmaceuticals | |
12/2000 | Proteome | |
1/1998 | Synteni |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|